Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Bharat Biotech allowed COVAXIN trials on children aged 12+
  • India

    Bharat Biotech allowed COVAXIN trials on children aged 12+

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Jan 04, 2021, 06:56 pm
    Bharat Biotech allowed COVAXIN trials on children aged 12+
  • Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.

    On Sunday, the firm's vaccine, called COVAXIN, had been granted emergency approval for use, albeit in "clinical trial mode" only.

    The vaccine has been undergoing Phase III trials and its efficacy is yet to be ascertained.

    Here are more details.

  • In this article
    Yesterday, government had approved two vaccines COVAXIN already administered to children in last round of trials Questions raised over vaccine's efficacy with trial still underway COVAXIN more effective against mutated virus: ICMR chief 'mRNA vaccines may not work as well against mutated virus'
  • Vaccination

    Yesterday, government had approved two vaccines

    Yesterday, government had approved two vaccines
  • On Sunday, the government had approved two vaccines: COVAXIN and Covishield (developed by AstraZeneca and Oxford University, and manufactured by Pune-based Serum Institute of India).

    So far, the government has said the vaccination drive will only focus on adults.

    However, COVAXIN has been approved in "clinical trial mode," i.e., its recipients would be tracked and monitored as if they were in a clinical trial.

  • Information

    COVAXIN already administered to children in last round of trials

  • Notably, COVAXIN has already been given to children above the age of 12 in the last round of trials. It has been found "safe" so far. Phase I and II trials also showed that the vaccine had a "robust immune response."

  • Controversy

    Questions raised over vaccine's efficacy with trial still underway

    Questions raised over vaccine's efficacy with trial still underway
  • The approval for restricted use for COVAXIN has invited controversy as the company is yet to complete clinical trials and submit data on efficacy.

    The Opposition has demanded that the vaccine's use should be avoided until the trials have concluded.

    Meanwhile, Health Minister Dr. Harsh Vardhan has said that the Opposition was politicizing a "critical issue," adding that "science-backed protocols" were followed for approval.

  • Advantage

    COVAXIN more effective against mutated virus: ICMR chief

    COVAXIN more effective against mutated virus: ICMR chief
  • COVAXIN is an inactivated vaccine, i.e., it uses an inactivated or killed pathogen (SARS-CoV-2) to trigger an immune response.

    Indian Council of Medical Research (ICMR) Director-General Dr. Balram Bhargava told The Print that the vaccine is more likely to act against the new mutant strain of the coronavirus as it uses the whole virus.

    The ICMR has jointly developed COVAXIN with Bharat Biotech.

  • Quote

    'mRNA vaccines may not work as well against mutated virus'

  • Dr. Bhargava said, "If there are say 1,000 points in a vaccine, of which two have mutated, this is still going to have 998 points to generate a response, unlike others such as mRNA vaccines, which...may not work as well when those areas mutate."

  • Indian Council of Medical Research
  • Oxford University
  • Harsh Vardhan
  • Coronavirus
  • Bhargava
  •  
Latest News
  • ASCI drafts promotional content guidelines for social media influencers
    ASCI drafts promotional content guidelines for social media influencers
    Business
  • Daft Punk split after 28 years: Details here
    Daft Punk split after 28 years: Details here
    Entertainment
  • Ford Aspire CNG variant spotted testing in India, launch imminent
    Ford Aspire CNG variant spotted testing in India, launch imminent
    Auto
  • Vivo releases Android 11 update for V20 SE in India
    Vivo releases Android 11 update for V20 SE in India
    Science
  • Spotify takes on Tidal with new 'HiFi' lossless audio plan
    Spotify takes on Tidal with new 'HiFi' lossless audio plan
    Science
Related Timelines
  • All you need to know about vaccines approved in India
    All you need to know about vaccines approved in India
    India
  • How Delhi plans to carry out COVID-19 vaccinations
    How Delhi plans to carry out COVID-19 vaccinations
    India
  • Here's how the government is planning to conduct COVID-19 vaccinations
    Here's how the government is planning to conduct COVID-19 vaccinations
    India
  • No emergency approval for SII, Bharat Biotech's vaccine candidates yet
    No emergency approval for SII, Bharat Biotech's vaccine candidates yet
    Science
Trending Topics
ISRO Vaccine Farmers Protest Uttarakhand Glacier Disaster
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda Batman
Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota Fashion Tips Farmers Protest
Mercedes Barcelona La Liga Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers
Neha Kakkar Premier League Big Bang Theory X-Men
About Us Privacy Policy Terms & Conditions Contact Us News News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021